Podcast discusses experimental brain-aging approaches, from stem cells to gene therapy
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →At a glance
Automatic summary · not editorially reviewedIn this podcast episode, Dr. Esra Çavuşoğlu talks with Dr. Vincent Giampapa about experimental approaches to brain aging, including stem cells, gene therapy, focused ultrasound and exosomes, and their possible roles in Alzheimer's, Parkinson's and memory loss. The description calls these approaches still experimental. [1]
The description introduces Dr. Vincent Giampapa as a physician, plastic and reconstructive surgeon and researcher in regenerative and anti-aging medicine. [1]
The description lists the hypothalamus, epigenetic reprogramming, the Klotho gene, mitochondrial health and regenerative medicine among the episode's topics. [1]
The description says the episode explores possible roles of these approaches in Alzheimer's disease, Parkinson's disease, memory loss and cognitive health. [1]
Giampapa's background and the episode's brain-aging focus
The description introduces Dr. Vincent Giampapa as an American physician, plastic and reconstructive surgeon and researcher in regenerative and anti-aging medicine. It says he co-founded the American Academy of Anti-Aging Medicine and works on stem cell therapies, cellular regeneration and the biology of aging. Host Dr. Esra Çavuşoğlu frames the episode around whether brain aging can be slowed or perhaps reversed one day, and around emerging research into brain rejuvenation, cognitive decline and longevity medicine. [1]
Topics listed: hypothalamus, Klotho, mitochondria and reprogramming
The description lists topics the episode explores: the hypothalamus as a possible central regulator of aging throughout the body, epigenetic reprogramming, the Klotho gene, mitochondrial health and regenerative medicine. It also names stem cells, gene therapy, focused ultrasound and exosomes as approaches that might help protect the aging brain. The description presents these as some of the most promising but still experimental approaches to extending brain healthspan. [1]
Disease context and the open question of resetting the clock
According to the description, the conversation covers potential roles of these approaches in Alzheimer's disease, Parkinson's disease, memory loss and cognitive health. It also asks whether the brain's biological clock can really be reset or whether understanding of these technologies is still at the beginning. The description does not report study designs, participant numbers, outcomes or safety data; it frames the material as informational and experimental. [1]
Context & limits
This explainer is based only on the video description. The video and transcript were not reviewed, so no study designs, participant numbers, results or safety data can be confirmed. The description itself calls the approaches still experimental and gives informational content only, not medical guidance.
Based on the creator’s description; the full video and transcript were not analyzed.
Quoted passages in the original language
plastic and reconstructive surgeon, and researcher
From epigenetic reprogramming and the Klotho gene
Alzheimer's disease, Parkinson's disease, memory loss
About this video
Creator description · original textText language: Turkish
Ayık Kafa · 65 min · Source published: 2026-10-22
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.